Biogen teams with NeuroSense to explore ALS neurofilament biomarker

Biogen has entered into a collaborative agreement with NeuroSense Therapeutics to assess the latter’s amyotrophic lateral sclerosis candidate PrimeC, the Israeli biotech announced in an SEC filing posted Tuesday.